Blood Advances in a Different Vein

Blood Advances in a Different Vein

Research from recent issues of Blood Advances

High Rates of Depression Resulting in Higher Health-Care Costs in Patients With Sickle Cell...

Depression is approximately five times more prevalent in patients with sickle cell disease (SCD) than in the general population, and it is significantly associated...

Study Finds Cancer Risk is Higher Than Expected Among Patients With Pregnancy-Related VTE

Venous thromboembolism (VTE) is associated with an increased prevalence of occult cancer. As pregnancy is also associated with an increased risk of VTE, it...

Can Reduced-Dose Rituximab Effectively Prevent TTP Recurrence?

Previous research suggests that the anti-CD20 monoclonal antibody rituximab, at a dose of 375 mg/m2, can prevent relapse in patients with thrombotic thrombocytopenic purpura...

Managing Toxicities of Dasatinib in Patients With CP-CML

In randomized studies, the second-generation tyrosine kinase inhibitor dasatinib demonstrated deeper and more rapid major molecular responses (MRs) in patients with newly diagnosed chronic-phase...

Are HCT Patients in Brazil at Increased Risk of Zika and Other Mosquito-Transmitted Infections?

Since 2015, Brazil has experienced a triple epidemic of dengue, chikungunya, and Zika infections, putting the more than 2,000 hematopoietic cell transplantation (HCT) recipients...

Long-Term Study Highlights Limitations of Current TTP Diagnostic Methods

For the past two decades, ADAMTS13 activity has been the backbone of diagnosis for thrombotic thrombocytopenic purpura (TTP); however, a long-term registry study published...

Investigating Trends in Survival Outcomes Among the Oldest Patients with DLBCL

The probability of developing non-Hodgkin lymphoma (NHL) increases with age. Thus, as the U.S. population ages, a greater number of patients are at risk...

Examining Hemoglobin Variants and Geographic Variability of Sickle Cell Trait and Sickle Cell Disease...

Results from the prospective Uganda Sickle Surveillance Study (US3), which was created through a partnership among the Uganda Ministry of Health, Makerere University, and...

Newly Identified DNA Mutations Predict for Worse Survival Among Patients With Polycythemia Vera and...

The driver mutations JAK2, CALR, and MPL have prognostic and diagnostic significance for patients with the myeloproliferative neoplasms polycythemia vera (PV) and essential thrombocythemia...
Advertisement

Current Issue

December 2017, Volume 3, Issue 14

This issue features physicians' insights on gun control, the use of cannabis for symptom relief, and more.